Skip to main content
Clinical Trials/NCT06140368
NCT06140368
Completed
Not Applicable

The Effect of Virtual Reality on Pain, Anxiety and Patient Comfort During Trigger Point Injection

Izmir Bakircay University1 site in 1 country84 target enrollmentMay 10, 2023
ConditionsVirtual Reality

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Virtual Reality
Sponsor
Izmir Bakircay University
Enrollment
84
Locations
1
Primary Endpoint
State Anxiety Scale
Status
Completed
Last Updated
4 months ago

Overview

Brief Summary

To determine the effects of virtual reality application during trigger point injection on patients' pain, anxiety and comfort levels.This research was planned as a randomized controlled experimental type. The population of the research was planned to include patients who applied to the Algology polyclinic for trigger point injection. The sample of the research will consist of 150 patients who meet the sampling criteria and agree to participate in the research.Inclusion criteria: Trigger point injection applied for the first time, 18 years and over, understand and speak Turkish, understand verbal and written information given.Patients will be divided into two groups: experimental (virtual reality) and control groups.Data will be collected with the Case Report Form, State Anxiety Scale, General Comfort Scale and Visual Analog Scale.Patients' anxiety, comfort and pain levels will be evaluated before and after trigger point injection.

Detailed Description

Patients in the experimental group will be shown videos that the patient wants to watch, such as nature and seaside walks, underwater videos, with music background, through virtual reality glasses for 10 minutes.Patients in the control group will continue routine practice.Patients' anxiety, comfort and pain levels will be evaluated before and after trigger point injection.

Registry
clinicaltrials.gov
Start Date
May 10, 2023
End Date
December 10, 2023
Last Updated
4 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Izmir Bakircay University
Responsible Party
Principal Investigator
Principal Investigator

Elif Günay İsmailoğlu

Associate Professor

Izmir Bakircay University

Eligibility Criteria

Inclusion Criteria

  • The procedure will be applied for the first time
  • 18 years and over
  • Able to understand and speak Turkish
  • Able to understand verbal and written information given
  • Having good cognitive abilities
  • Without visual or hearing loss
  • Patients who agreed to participate in the study

Exclusion Criteria

  • Those who do not understand or speak Turkish
  • Does not understand verbal and written information
  • Those with impaired cognitive abilities

Outcomes

Primary Outcomes

State Anxiety Scale

Time Frame: 10 minutes after procedure

The scale developed by Spielberger et al. aims to measure state and trait anxiety levels separately.The scores obtained from the scale vary between 20-80, and the total score between 20-39 indicates mild anxiety, between 40-59 indicates moderate anxiety, and between 60-79 indicates severe anxiety.

General Comfort Scale

Time Frame: 10 minutes after procedure

The scale, which was developed by Kolcaba in 2006 and has a total of 28 questions as 'Refreshing (9 items), Relaxation (9 items) and Overcoming Problems (10 items), consists of three sub-dimensions.The lowest value that can be taken is 1, which indicates low comfort, and the highest value, 6, indicates high comfort.

Visual Analog Scale

Time Frame: In the middle (10 minutes) of the procedure

It is aimed to determine the level of pain.0 means no pain and 10 means maximum pain

Study Sites (1)

Loading locations...

Similar Trials